EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay

Haley K Andersen, Duncan G Vardakas, Julie A Lamothe, Tannis E A Perault, Kenneth B Walsh, Robert B Laprairie

Scientific Reports · 2024

DOI: 10.1038/s41598-024-68451-2 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Scientific Reports, 2024. Verfasst von Haley K Andersen und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, G Protein-Coupled Inwardly-Rectifying Potassium Channels, Naphthalenes, Benzoxazines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, University of Saskatchewan, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The type 1 cannabinoid receptor (CB1R) mediates neurotransmitter release and synaptic plasticity in the central nervous system. Endogenous, plant-derived, synthetic cannabinoids bind to CB1R, initiating the inhibitory G-protein (G i ) and the β-arrestin signaling pathways. Within the G i signaling pathway, CB1R activates G protein-gated, inwardly-rectifying potassium (GIRK) channels. The β-arrestin pathway reduces CB1R expression on the cell surface through receptor internalization. Because of their association with analgesia and drug tolerance, GIRK channels and receptor internalization are of interest to the development of pharmaceuticals. This research used immortalized mouse pituitary gland cells transduced with a pH-sensitive, fluorescently-tagged human CB1R (AtT20-SEPCB1) to measure GIRK channel activity and CB1R internalization. Cannabinoid-induced GIRK channel activity is measured by using a fluorescent membrane-potential sensitive dye. We developed a kinetic imaging assay that visualizes and measures CB1R internalization. All cannabinoids stimulated a GIRK channel response with a rank order potency of WIN55,212-2 > (±)CP55,940 > Δ 9 -THC > AEA. Efficacy was expressed relative to (±)CP55,940 with a rank order efficacy of (±)CP55,940 > WIN55, 212-2 > AEA > Δ 9 -THC. All cannabinoids stimulated CB1R internalization with a rank order potency of (±)CP55,940 > WIN55, 212-2 > AEA > Δ 9 -THC. Internalization efficacy was normalized to (±)CP55,940 with a rank order efficacy of WIN55,212-2 > AEA > (±)CP55,940 > Δ 9 -THC. (±)CP55,940 was significantly more potent and efficacious than AEA and Δ 9 -THC at stimulating a GIRK channel response; no significant differences between potency and efficacy were observed with CB1R internalization. No significant differences were found when comparing a cannabinoid’s GIRK channel and CB1R internalization response. In conclusion, AtT20-SEPCB1 cells can be used to assess cannabinoid-induced CB1R internalization. While cannabinoids display differential G i signaling when compared to each other, this did not extend to CB1R internalization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB1G Protein-Coupled Inwardly-Rectifying Potassium ChannelsNaphthalenesBenzoxazinesAnimalsMiceHumansKineticsCannabinoidsMorpholinesSignal TransductionCell LineCyclohexanols

Stichwörter der Autor:innen

CannabinoidCannabinoid receptorG protein-coupled receptorReal-time assayReceptor signalingReceptor trafficking

Substanzen

Receptor, Cannabinoid, CB1G Protein-Coupled Inwardly-Rectifying Potassium ChannelsNaphthalenesBenzoxazines(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneCannabinoidsMorpholines3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanolCyclohexanols

Autor:innen und Institutionen

  • College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.
  • Pharmacology, Physiology, and Neuroscience, School of Medicine Columbia, University of South Carolina, Columbia, SC, USA.
  • College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada. robert.laprairie@usask.ca.
  • Department of Pharmacology, College of Medicine, Dalhousie University, Halifax, NS, Canada. robert.laprairie@usask.ca.

Förderung

  • CIHR
  • University of Saskatchewan
  • Canadian Institutes of Health Research

Zitieren

APA

Andersen, H. K., Vardakas, D. G., Lamothe, J. A., Perault, T. E. A., Walsh, K. B., & Laprairie, R. B. (2024). Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay. Scientific Reports. https://doi.org/10.1038/s41598-024-68451-2

Vancouver

Andersen HK, Vardakas DG, Lamothe JA, Perault TEA, Walsh KB, Laprairie RB. Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay. Scientific Reports. 2024. doi:10.1038/s41598-024-68451-2

BibTeX
@article{Andersen2024,
  author = {Andersen, Haley K and Vardakas, Duncan G and Lamothe, Julie A and Perault, Tannis E A and Walsh, Kenneth B and Laprairie, Robert B},
  title = {Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay},
  journal = {Scientific Reports},
  year = {2024},
  doi = {10.1038/s41598-024-68451-2}
}
Kostenlos starten →